Scott Dunseth Myers Harpoon Therapeutics, Inc. (HARP) insider trading activity

Scott Dunseth Myers is of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2024, when has been sold 22,665 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Scott Dunseth Myers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2024	SELL Sale (or disposition) back to the issuer	-	22,665 Reduced 100.0%	0 Common Stock
Jan 01 2024	BUY Grant, award, or other acquisition	-	2,048 Added 8.29%	22,666 Common Stock
Nov 27 2023	BUY Grant, award, or other acquisition	-	5,000 Added 19.52%	20,618 Common Stock
Oct 01 2023	BUY Grant, award, or other acquisition	-	5,797 Added 27.07%	15,618 Common Stock
Jul 01 2023	BUY Grant, award, or other acquisition	-	35,634 Added 26.62%	98,215 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	-	34,925 Added 35.82%	62,581 Common Stock

Also insider at

AMAG

AMAG PHARMACEUTICALS, INC.

President & CEO

SELB

SELECTA BIOSCIENCES INC Healthcare

Director

DVAX

DYNAVAX TECHNOLOGIES CORP Healthcare

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Chief Executive Officer

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

Director

SDM